Response to alectinib oil-based suspension in anaplastic lymphoma kinase-positive non-small cell lung cancer in a patient unable to swallow: A case report

The emergence of oral targeted therapy in the management of non-small cell lung cancer with targetable oncogenes has led to significant improvements in progression-free survival, toxicity profile, and quality of life compared to intravenous chemotherapy. However, patients unable to swallow or with e...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of oncology pharmacy practice 2019-10, Vol.25 (7), p.1722-1725
Hauptverfasser:	Bejarano Varas, Maria Teresa, Gould, Scott, Charlot, Marjory
Format:	Artikel
Sprache:	eng
Schlagworte:	Case reports Chemotherapy Enteral feeding Formulations Intravenous administration Lung cancer Lymphoma Metastases Non-small cell lung carcinoma Protein-tyrosine kinase Quality of life Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!